- Home
- FRGE vs XOMA Comparison
FRGE vs XOMA Comparison
Compare FRGE & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRGE | XOMA |
|---|---|---|
| Founded | 2014 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 354.6M | 397.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FRGE | XOMA |
|---|---|---|
| Price | $44.42 | $26.44 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $38.25 | ★ $63.25 |
| AVG Volume (30 Days) | ★ 642.2K | 74.5K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.82 |
| Revenue | ★ $92,884,000.00 | $47,106,000.00 |
| Revenue This Year | $33.10 | $77.23 |
| Revenue Next Year | $24.07 | $17.97 |
| P/E Ratio | ★ N/A | $32.30 |
| Revenue Growth | 16.40 | ★ 118.02 |
| 52 Week Low | $6.60 | $18.35 |
| 52 Week High | $44.76 | $39.92 |
Technical Indicators
Market Signals| Indicator | FRGE | XOMA |
|---|---|---|
| Relative Strength Index (RSI) | 86.33 | 34.68 |
| Support Level | $44.29 | $29.60 |
| Resistance Level | $44.41 | $34.79 |
| Average True Range (ATR) | 0.19 | 1.79 |
| MACD | -0.92 | -0.09 |
| Stochastic Oscillator | 93.81 | 10.98 |
Price Performance
Historical ComparisonAbout FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.